Lataa...
Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial
OBJECTIVES: This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (≥2 months) use of tiotropium HandiHaler 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients...
Tallennettuna:
| Julkaisussa: | BMJ Open |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710815/ https://ncbi.nlm.nih.gov/pubmed/26715479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009015 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|